Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.23.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue:    
Products, services, other $ 740,600 $ 480,000
Total revenue 740,600 480,000
Costs and expenses:    
Cost of products and services 358,628 314,363
Research and development 435,646 281,589
Selling and marketing 226,015 66,462
General and administrative 3,358,056 903,885
Total operating costs 4,378,345 1,566,299
Operating loss (3,637,745) (1,086,299)
Other (expense) income:    
Interest expense, net (3,893,686) (2,579,161)
Unrealized gain on investment in equity securities 8,061 19,138
Gain (loss) on extinguishment of liabilities 659,277 (589,850)
Other income (expense) 6,259 (3,513)
Total other expense (3,220,089) (3,153,386)
Net loss (6,857,834) (4,239,685)
Preferred stock dividends (431,807) (432,149)
Net loss attributable to common shareholders $ (7,289,641) $ (4,671,834)
Basic and diluted net loss per share attributable to common shareholders $ (0.46) $ (0.48)
Weighted average common shares outstanding used in the basic and diluted net loss per share calculation 15,839,373 9,695,189